Livaramed exists because the medical system told a father his daughter's five-year illness was "just anxiety" — and he refused to accept it. What began as one family's fight is now a patent-pending diagnostic engine with the highest published accuracy on medicine's hardest benchmark.
Co-Founder & Chief Executive Officer
Four decades of entrepreneurial leadership across technology and healthcare ventures — and the father who would not take "it's just anxiety" for an answer. Doug drives product vision, clinical direction, and the company's mission: no patient left undiagnosed for lack of someone looking at the whole picture.
Co-Founder & Chief Technology Officer
Former practicing attorney turned full-stack engineer — the architect of the Livaramed platform from infrastructure to the CrucibleDx adversarial pipeline. Bruce is co-inventor on the company's patent filings and leads engineering, security, and the benchmark program.
Livaramed is a product of Brown Innovations & Solutions, LLC, a family-held company founded by brothers Doug and Bruce Brown. Sister product: NeuralCalm, an AI-powered anxiety-intervention platform.
U.S. Provisional Patent Application No. 64/071,743 (filed May 21, 2026): Multi-Model Adversarial Medical Analysis System with Temporal Verification, Mechanical Demotion Guard, and Deterministic Drug Safety Verification — 70 claims, 25 figures, every feature implemented in production code.
CrucibleDx placed the correct diagnosis in its top 3 on 91.3% of 300 NEJM Case Records (58.3% at rank #1) — the highest published accuracy on NEJM CPC cases. A preprint and journal submission are in preparation. See the evidence →
For interviews, the press kit, benchmark methodology, or comment on medical AI: support@livaramed.com. The founding story — five years undiagnosed, an unnecessary heart surgery, and the engine a father built in response — is told in full at Story.